Sonnet biotherapeutics to present clinical data from the sb101 study with son-1010 at the aacr 2023 annual meeting
Princeton, nj / accesswire / march 14, 2023 / sonnet biotherapeutics holdings, inc. (nasdaq:sonn) ("sonnet" or the "company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced today that data from the company-sponsored sb101 multiple-dose clinical trial (nct05352750) of son-1010 (il12-fhab) in adult patients with advanced solid tumors will be presented in a poster session at the upcoming american association for cancer research (aacr) annual meeting 2023, to be held april 14-19, in orlando, florida. presentation details: title: clinical development of a novel form of interleukin-12 with extended pharmacokinetics session title: phase i and first-in-human clinical trials in progress presentation type: poster session date and time: tuesday april 18, 2023, 1:30 pm - 5:00 pm abstract number: ct245 location: poster section 46 about sonnet biotherapeutics holdings, inc. sonnet biotherapeutics is an oncology-focused biotechnology company with a proprietary platform for innovating biologic drugs of single or bispecific, bifunctional action.
SONN Ratings Summary
SONN Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission